Treg Depletion–enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus

There are several roadblocks that hinder systemic delivery of oncolytic viruses to the sites of metastatic disease. These include the tumor vasculature, which provides a physical barrier to tumor-specific virus extravasation. Although interleukin-2 (IL-2) has been used in antitumor therapy, it is as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kottke, Timothy, Galivo, Feorillo, Wongthida, Phonphimon, Diaz, Rosa Maria, Thompson, Jill, Jevremovic, Dragan, Barber, Glen N, Hall, Geoff, Chester, John, Selby, Peter, Harrington, Kevin, Melcher, Alan, Vile, Richard G
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729455/
https://ncbi.nlm.nih.gov/pubmed/18431359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2008.83
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares